Production (Stage)
Purple Biotech Ltd
PPBT
$2.62
$0.0050.19%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -16.03M | -18.76M | -19.88M | |
| Total Depreciation and Amortization | -- | 195.00K | 199.00K | 197.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -2.73M | -1.46M | -516.00K | |
| Change in Net Operating Assets | -- | 865.00K | 1.08M | 274.00K | |
| Cash from Operations | -- | -17.70M | -18.94M | -19.93M | |
| Capital Expenditure | -- | 1.00K | 0.00 | -3.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | 0.00 | 0.00 | -3.55M | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 1.48M | 1.59M | 17.43M | |
| Cash from Investing | -- | 1.48M | 1.59M | 13.88M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -175.00K | -171.00K | -168.00K | |
| Issuance of Common Stock | -- | 1.62M | 1.54M | 1.56M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | 4.07M | 4.08M | 4.05M | |
| Cash from Financing | -- | 5.52M | 5.45M | 5.45M | |
| Foreign Exchange rate Adjustments | -- | 20.00K | 2.00K | 54.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -10.68M | -11.90M | -541.00K | |